AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy

Daoming Zhu1,§Ruoyu Ling1,§Hao Chen1,§Meng Lyu4Haisheng Qian2Konglin Wu3( )Guoxin Li1( )Xianwen Wang2( )
Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China
School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei 230032, China
Institute of Clean Energy and Advanced Nanocatalysis, School of Chemistry and Chemical Engineering, Anhui University of Technology, Maanshan 243002, China
Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

§ Daoming Zhu, Ruoyu Ling, and Hao Chen contributed equally to this work.

Show Author Information

Graphical Abstract

A biomimetic single-atom nanozyme system was developed for self-enhanced nanocatalytic tumor therapy, which obtained satisfactory therapeutic effect.

Abstract

Single-atom nanozymes (SAZs) with peroxidase (POD)-like activity have good nanocatalytic tumor therapy (NCT) capabilities. However, insufficient hydrogen peroxide (H2O2) and hydrogen ions in the cells limit their therapeutic effects. Herein, to overcome these limitations, a biomimetic single-atom nanozyme system was developed for self-enhanced NCT. We used a previously described approach to produce platelet membrane vesicles. Using a high-temperature carbonization approach, copper SAZs with excellent POD-like activity were successfully synthesized. Finally, through physical extrusion, a proton pump inhibitor (PPI; pantoprazole sodium) and the SAZs were combined with platelet membrane vesicles to create PPS. Both in vivo and in vitro, PPS displayed good tumor-targeting and accumulation abilities. PPIs were able to simultaneously regulate the hydrogen ion, glutathione (GSH), and H2O2 content in tumor cells, significantly improve the catalytic ability of SAZs, and achieve self-enhanced NCT. Our in vivo studies showed that PPS had a tumor suppression rate of > 90%. PPS also limited the synthesis of GSH in cells at the source; thus, glutamine metabolism therapy and NCT were integrated into an innovative method, which provides a novel strategy for multimodal tumor therapy.

Electronic Supplementary Material

Download File(s)
12274_2022_4359_MOESM1_ESM.pdf (1.2 MB)

References

1

Wang, Y.; Zheng, X. B.; Wang, D. S. Design concept for electrocatalysts. Nano Res. 2022, 15, 1730–1752.

2
Jing, H. Y. ; Zhu, P. ; Zheng, X. B. ; Zhang, Z. D. ; Wang, D. S. ; Li, Y. D. Theory-oriented screening and discovery of advanced energy transformation materials in electrocatalysis. Adv. Powder Mater. 2021, in press, https://doi.org/10.1016/j.apmate.2021.10.004.
3

Li, W. H.; Yang, J. R.; Jing, H. Y.; Zhang, J.; Wang, Y.; Li, J.; Zhao, J.; Wang, D. S.; Li, Y. D. Creating high regioselectivity by electronic metal–support interaction of a single-atomic-site catalyst. J. Am. Chem. Soc. 2021, 143, 15453–15461.

4

Yang, J. R.; Li, W. H.; Tan, S. D.; Xu, K. N.; Wang, Y.; Wang, D. S.; Li, Y. D. The electronic metal–support interaction directing the design of single atomic site catalysts: Achieving high efficiency towards hydrogen evolution. Angew. Chem. 2021, 133, 19233–19239.

5

Han, A. L.; Wang, X. J.; Tang, K.; Zhang, Z. D.; Ye, C. L.; Kong, K. J.; Hu, H. B.; Zheng, L. R.; Jiang, P.; Zhao, C. X. et al. An adjacent atomic platinum site enables single-atom iron with high oxygen reduction reaction performance. Angew. Chem., Int. Ed. 2021, 60, 19262–19271.

6

Liu, Z. H.; Du, Y.; Zhang, P. F.; Zhuang, Z. C.; Wang, D. S. Bringing catalytic order out of chaos with nitrogen-doped ordered mesoporous carbon. Matter 2021, 4, 3161–3194.

7

Xiong, Y.; Sun, W. M.; Han, Y. H.; Xin, P. Y.; Zheng, X. S.; Yan, W. S.; Dong, J. C.; Zhang, J.; Wang, D. S.; Li, Y. D. Cobalt single atom site catalysts with ultrahigh metal loading for enhanced aerobic oxidation of ethylbenzene. Nano Res. 2021, 14, 2418–2423.

8

Chen, Y. J.; Gao, R.; Ji, S. F.; Li, H. J.; Tang, K.; Jiang, P.; Hu, H. B.; Zhang, Z. D.; Hao, H. G.; Qu, Q. Y. et al. Atomic-level modulation of electronic density at cobalt single-atom sites derived from metal-organic frameworks: Enhanced oxygen reduction performance. Angew. Chem., Int. Ed. 2021, 60, 3212–3221.

9

Zhang, S. L.; Ao, X.; Huang, J.; Wei, B.; Zhai, Y. L.; Zhai, D.; Deng, W. Q.; Su, C. L.; Wang, D. S.; Li, Y. D. Isolated single-atom Ni-N5 catalytic site in hollow porous carbon capsules for efficient lithium-sulfur batteries. Nano Lett. 2021, 21, 9691–9698.

10

Zhang, N. Q.; Zhang, X. X.; Tao, L.; Jiang, P.; Ye, C. L.; Lin, R.; Huang, Z. W.; Li, A.; Pang, D. W.; Yan, H. et al. Silver single-atom catalyst for efficient electrochemical CO2 reduction synthesized from thermal transformation and surface reconstruction. Angew. Chem., Int. Ed. 2021, 60, 6170–6176.

11

Gao, G.; Jiang, Y. W.; Guo, Y. X.; Jia, H. R.; Cheng, X. T.; Deng, Y.; Yu, Y. X.; Zhu, Y. X.; Guo, H. Y.; Sun, W. et al. Enzyme-mediated tumor starvation and phototherapy enhance mild-temperature photothermal therapy. Adv. Funct. Mater. 2020, 30, 1909391.

12

Chang, M. Y.; Hou, Z. Y.; Wang, M.; Yang, C. Z.; Wang, R. F.; Li, F.; Liu, D. L.; Peng, T. L.; Li, C. X.; Lin, J. Single-atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy. Angew. Chem., Int. Ed. 2021, 60, 12971–12979.

13

Zhu, Y.; Wang, W. Y.; Cheng, J. J.; Qu, Y. T.; Dai, Y.; Liu, M. M.; Yu, J. N.; Wang, C. M.; Wang, H. J.; Wang, S. C. et al. Stimuli-responsive manganese single-atom nanozyme for tumor therapy via integrated cascade reactions. Angew. Chem. 2021, 133, 9566–9574.

14

Zhang, R. F.; Yan, X. Y.; Fan, K. L. Nanozymes inspired by natural enzymes. Acc. Mater. Res. 2021, 2, 534–547.

15

Han, A. J.; Chen, W. X.; Zhang, S. L.; Zhang, M. L.; Han, Y. H.; Zhang, J.; Ji, S. F.; Zheng, L. R.; Wang, Y.; Gu, L. et al. A polymer encapsulation strategy to synthesize porous nitrogen-doped carbon-nanosphere-supported metal isolated-single-atomic-site catalysts. Adv. Mater. 2018, 30, 1706508.

16

Huang, L.; Chen, J. X.; Gan, L. F.; Wang, J.; Dong, S. J. Single-atom nanozymes. Sci. Adv. 2019, 5, eaav5490.

17

Huo, M. F.; Wang, L. Y.; Wang, Y. W.; Chen, Y.; Shi, J. L. Nanocatalytic tumor therapy by single-atom catalysts. ACS Nano 2019, 13, 2643–2653.

18

Jiao, L.; Yan, H. Y.; Wu, Y.; Gu, W. L.; Zhu, C. Z.; Du, D.; Lin, Y. H. When nanozymes meet single-atom catalysis. Angew. Chem., Int. Ed. 2020, 59, 2565–2576.

19

Zhao, C.; Xiong, C.; Liu, X. K.; Qiao, M.; Li, Z. J.; Yuan, T. W.; Wang, J.; Qu, Y. T.; Wang, X. Q.; Zhou, F. Y. et al. Unraveling the enzyme-like activity of heterogeneous single atom catalyst. Chem. Commun 2019, 55, 2285–2288.

20

Ji, S. F.; Jiang, B.; Hao, H. G.; Chen, Y. J.; Dong, J. C.; Mao, Y.; Zhang, Z. D.; Gao, R.; Chen, W. X.; Zhang, R. F. et al. Matching the kinetics of natural enzymes with a single-atom iron nanozyme. Nat. Catal. 2021, 4, 407–417.

21

Cao, F. F.; Zhang, L.; You, Y. W.; Zheng, L. R.; Ren, J. S.; Qu, X. G. An enzyme-mimicking single-atom catalyst as an efficient multiple reactive oxygen and nitrogen species scavenger for sepsis management. Angew. Chem., Int. Ed. 2020, 59, 5108–5115.

22

Wang, X.; Zhao, Y. B.; Shi, L.; Hu, Y.; Song, G. B.; Cai, K. Y.; Li, M. H.; Luo, Z. Tumor-targeted disruption of lactate transport with reactivity-reversible nanocatalysts to amplify oxidative damage. Small 2021, 17, 2100130.

23

Fu, L. H.; Hu, Y. R.; Qi, C.; He, T.; Jiang, S. S.; Jiang, C.; He, J.; Qu, J. L.; Lin, J.; Huang, P. Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy. ACS Nano 2019, 13, 13985–13994.

24

Liu, Y.; Zhen, W. Y.; Jin, L. H.; Zhang, S. T.; Sun, G. Y.; Zhang, T. Q.; Xu, X.; Song, S. Y.; Wang, Y. H.; Liu, J. H. et al. All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication. ACS Nano 2018, 12, 4886–4893.

25

Meng, X. Q.; Li, D. D.; Chen, L.; He, H. L.; Wang, Q.; Hong, C. Y.; He, J. Y.; Gao, X. F.; Yang, Y. L.; Jiang, B. et al. High-performance self-cascade pyrite nanozymes for apoptosis-ferroptosis synergistic tumor therapy. ACS Nano 2021, 15, 5735–5751.

26

Altman, B. J.; Stine, Z. E.; Dang, C. V. From Krebs to clinic: Glutamine metabolism to cancer therapy. Nat. Rev. Cancer 2016, 16, 619–634.

27

Niu, B. Y.; Liao, K. X.; Zhou, Y. X.; Wen, T.; Quan, G. L.; Pan, X.; Wu, C. B. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials 2021, 277, 121110.

28

Welbourne, T. C. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can. J. Biochem. 1979, 57, 233–237.

29

Wang, L.; Huang, X. J.; You, X. R.; Yi, T. Q.; Lu, B.; Liu, J. L.; Lu, G. H.; Ma, M. L.; Lu, G. H.; Ma, M. L. et al. Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma. Sig. Trans. Target. Ther. 2020, 5, 196.

30

Yang, Y.; Liu, X.; Ma, W.; Xu, Q.; Chen, G.; Wang, Y. F.; Xiao, H. H.; Li, N.; Liang, X. J.; Yu, M. et al. Light-activatable liposomes for repetitive on-demand drug release and immunopotentiation in hypoxic tumor therapy. Biomaterials 2021, 265, 120456.

31

Rubio, I.; Suva, L. J.; Todorova, V.; Bhattacharyya, S.; Kaufmann, Y.; Maners, A.; Smith, M.; Klimberg, V. S. Oral glutamine reduces radiation morbidity in breast conservation surgery. J. Parenter. Enteral Nutr. 2013, 37, 623–630.

32

Cao, Y. H.; Kennedy, R.; Klimberg, V. S. Glutamine protects against doxorubicin-induced cardiotoxicity. J. Surg. Res. 1999, 85, 178–182.

33

Reinfeld, B. I.; Madden, M. Z.; Wolf, M. M.; Chytil, A.; Bader, J. E.; Patterson, A. R.; Sugiura, A.; Cohen, A. S.; Ali, A.; Do, B. T. et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature 2021, 593, 282–288.

34

Xiao, Y. T.; Xiang, L. X.; Shao, J. Z. Vacuolar H+-ATPase. Int. J. Biochem. Cell Biol. 2008, 40, 2002–2006.

35

Luciani, F.; Spada, M.; De Milito, A.; Molinari, A.; Rivoltini, L.; Montinaro, A.; Marra, M.; Lugini, L.; Logozzi, M.; Lozupone, F. et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J. Natl. Cancer Inst. 2004, 96, 1702–1713.

36

Huang, Q.; Du, J.; Cheng, S. Q.; Gong, Z. C. Progress of proton pump inhibitors using in cancer patients. Chin. J. Clin. Pharmacol. Ther. 2018, 23, 1179–1187.

37

Xu, H. X.; Ren, D. J. Lysosomal physiology. Annu. Rev. Physiol. 2015, 77, 57–80.

38

Mayers, J. R.; Heiden, M. G. V. Famine versus feast: Understanding the metabolism of tumors in vivo. Trends Biochem. Sci. 2015, 40, 130–140.

39

Ye, H.; Wang, K. Y.; Wang, M. L.; Liu, R. Z.; Song, H.; Li, N.; Lu, Q.; Zhang, W. J.; Du, Y. Q.; Yang, W. Q. et al. Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials 2019, 206, 1–12.

40

Duo, Y. H.; Liu, Q.; Zhu, D. M.; Zhang, B.; Luo, G. H.; Wang, F. B.; Chen, J. H.; Cao, Y. H. Proof of concept for dual anticancer effects by a novel nanomaterial-mediated cancer cell killing and nano-radiosensitization. Chem. Eng. J. 2022, 429, 132328.

41

Fang, R. H.; Kroll, A. V.; Gao, W. W.; Zhang, L. F. Cell membrane coating nanotechnology. Adv. Mater. 2018, 30, 1706759.

42

Zhu, D. M.; Duo, Y. H.; Suo, M.; Zhao, Y. H.; Xia, L. G.; Zheng, Z.; Li, Y.; Tang, B. Z. Tumor-exocytosed exosome/aggregation-induced emission luminogen hybrid nanovesicles facilitate efficient tumor penetration and photodynamic therapy. Angew. Chem. 2020, 132, 13940–13947.

43

Ma, W. J.; Zhu, D. M.; Li, J. H.; Chen, X.; Xie, W.; Jiang, X.; Wu, L.; Wang, G. G.; Xiao, Y. S.; Liu, Z. S. et al. Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics 2020, 10, 1281–1295.

44

Shang, H. S.; Zhou, X. Y.; Dong, J. C.; Li, A.; Zhao, X.; Liu, Q. H.; Lin, Y.; Pei, J. J.; Li, Z.; Jiang, Z. L. et al. Engineering unsymmetrically coordinated Cu-S1N3 single atom sites with enhanced oxygen reduction activity. Nat. Commun. 2020, 11, 3049.

45

Jiang, Z. L.; Sun, W. M.; Shang, H. S.; Chen, W. X.; Sun, T. T.; Li, H. J.; Dong, J. C.; Zhou, J.; Li, Z.; Wang, Y. et al. Atomic interface effect of a single atom copper catalyst for enhanced oxygen reduction reactions. Energy Environ. Sci. 2019, 12, 3508–3514.

46

Chen, S. H.; Wang, B. Q.; Zhu, J. X.; Wang, L. Q.; Ou, H. H.; Zhang, Z. D.; Liang, X.; Zheng, L. R.; Zhou, L.; Su, Y. Q. et al. Lewis acid site-promoted single-atomic Cu catalyzes electrochemical CO2 methanation. Nano Lett. 2021, 21, 7325–7331.

47

Chen, S. H.; Li, W. H.; Jiang, W. J.; Yang, J. R.; Zhu, J. X.; Wang, L. Q.; Ou, H. H.; Zhuang, Z. C.; Chen, M. Z.; Sun, X. H. et al. MOF encapsulating N-heterocyclic carbene-ligated copper single-atom site catalyst towards efficient methane electrosynthesis. Angew. Chem., Int. Ed. 2022, 61, e202114450.

48

Ma, Q. L.; Fan, Q.; Xu, J. L.; Bai, J. Y.; Han, X.; Dong, Z. L.; Zhou, X. Z.; Liu, Z.; Gu, Z.; Wang, C. Calming cytokine storm in pneumonia by targeted delivery of TPCA-1 using platelet-derived extracellular vesicles. Matter 2020, 3, 287–301.

49

Ng, S. K.; Wood, J. P. M.; Chidlow, G.; Han, G. G.; Kittipassorn, T.; Peet, D. J.; Casson, R. J. Cancer-like metabolism of the mammalian retina. Clin. Exp. Ophthalmol. 2015, 43, 367–376.

50

Fu, Y. J.; Liu, S. S.; Yin, S. H. L.; Niu, W. H.; Xiong, W.; Tan, M.; Li, G. Y.; Zhou, M. The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy. Oncotarget 2017, 8, 57813–57825.

51

Upadhyay, M.; Samal, J.; Kandpal, M.; Singh, O. V.; Vivekanandan, P. The Warburg effect: Insights from the past decade. Pharmacol. Ther. 2013, 137, 318–330.

52

Lu, R. J.; Zhang, X. S.; Li, X. J.; Wan, X. F. Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605–5p/GLS axis. Int. J. Clin. Exp. Pathol. 2020, 13, 1791–1801.

53

Wang, R. J.; Xiang, W. Q.; Xu, Y.; Han, L. Y.; Li, Q. G.; Dai, W. X.; Cai, G. X. Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential. Ann Transl. Med. 2020, 8, 302.

54

Li, Q. C.; Tian, Y.; Liang, Y.; Li, C. CircHIPK3/miR-876–5p/PIK3R1 axis regulates regulation proliferation, migration, invasion, and glutaminolysis in gastric cancer cells. Cancer Cell Int. 2020, 20, 391.

55

Moreadith, R. W.; Lehninger, A. L. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J. Biol. Chem. 1984, 259, 6215–6221.

56

Sodi, V. L.; Khaku, S.; Krutilina, R.; Schwab, L. P.; Vocadlo, D. J.; Seagroves, T. N.; Reginato, M. J. mTOR/MYC axis regulates O-GlcNAc transferase expression and O-GlcNAcylation in breast cancer. Mol. Cancer Res. 2015, 13, 923–933.

57

Zhu, P.; Chen, Y.; Shi, J. L. Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation. ACS Nano 2018, 12, 3780–3795.

58

Huang, C. Y.; Ding, S. J.; Jiang, W.; Wang, F. B. Glutathione-depleting nanoplatelets for enhanced sonodynamic cancer therapy. Nanoscale 2021, 13, 4512–4518.

59

Song, G. S.; Cheng, L.; Chao, Y.; Yang, K.; Liu, Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv. Mater. 2017, 29, 1700996.

60

Gay, L. J.; Felding-Habermann, B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer. 2011, 11, 123–134.

61

Alves, C. S.; Burdick, M. M.; Thomas, S. N.; Pawar, P.; Konstantopoulos, K. The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am. J. Physiol. -Cell Physiol. 2008, 294, C907–C916.

62

Xu, L. L.; Gao, F.; Fan, F.; Yang, L. H. Platelet membrane coating coupled with solar irradiation endows a photodynamic nanosystem with both improved antitumor efficacy and undetectable skin damage. Biomaterials 2018, 159, 59–67.

63

Thiery, J. P.; Acloque, H.; Huang, R. Y. J.; Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139, 871–890.

64

Xu, M.; Gong, A. H.; Yang, H. Q.; George, S. K.; Jiao, Z. J.; Huang, H. M.; Jiang, X. M.; Zhang, Y. L. Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells. Cancer Lett. 2015, 369, 124–133.

Nano Research
Pages 7320-7328
Cite this article:
Zhu D, Ling R, Chen H, et al. Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy. Nano Research, 2022, 15(8): 7320-7328. https://doi.org/10.1007/s12274-022-4359-6
Topics:

1469

Views

80

Crossref

75

Web of Science

80

Scopus

1

CSCD

Altmetrics

Received: 31 December 2021
Revised: 07 March 2022
Accepted: 24 March 2022
Published: 24 May 2022
© Tsinghua University Press 2022
Return